-

Balancing Standardization and Innovation: Dr. Jin Li Shares Conference Highlights and the Future of AI in Clinical Research
The “2024 CSCO Digestive Tract Tumor Standardized Treatment Workshop,” co-hosted by the Chinese Society of Clinical Oncology, Beijing Xisike Clinical Oncology Research Foundation, and Hangzhou Oriental Clinical Oncology Research Center, was held in Shanghai from August 17-18, 2024. This workshop featured diverse learning methods, including lectures, discussions, and live surgical demonstrations, aimed at improving the…
-

In-Depth Analysis of UTUC MDT Diagnosis, Radiotherapy, and Translational Development, Pioneering the Path Forward with CUDA-UTUC
From August 8 to 11, 2024, the Annual Meeting of the Urological Surgeons Branch of the Chinese Medical Association (CUDA) was held in Xi’an. The conference was hosted by the Chinese Medical Association and the CUDA Urological Surgeons Branch, with the Air Force Medical University Xijing Hospital as the organizer and the Shaanxi Provincial Medical…
-

Hepatology丨Chinese Researchers Confirm that the EAT-Lancet Diet Significantly Reduces the Risk of Metabolic-Associated Fatty Liver Disease
Editor’s Note With the global rise in obesity, diabetes, and metabolic syndrome, the prevalence of metabolic-associated fatty liver disease (MASLD) is also increasing. Statistics show that MASLD has become one…
-

New Strategies for Bacterial STI Prevention: The CDC Officially Incorporates Doxy PEP into Guidelines
Editor’s Note: Recently, the U.S. Centers for Disease Control and Prevention (CDC) released an important clinical guideline offering new guidance on the prevention of bacterial sexually transmitted infections (STIs). The…
-

IDWeek丨Cutting-Edge Progress in HIV Prevention and Treatment: New Drugs and Innovative Diagnostic Technologies
Editor’s Note: The Infectious Diseases Week (IDWeek) is a premier global academic event in the field of infectious diseases, attracting nearly ten thousand experts and scholars annually to share the…
-

Gut丨HBcrAg Levels Can Predict Chronic Hepatitis B Patients’ Response to Interferon Therapy
Editor’s Note The current treatment options for chronic hepatitis B (CHB) primarily include long-term nucleos(t)ide analogs (NA) therapy and short-term interferon therapy. Although these approaches can control viral replication to…
-

2024 CUDA丨Dr. Guohua Zeng: China’s Leading Role in Minimally Invasive Urological Stone Surgery, Enhancing Patient Quality of Life
The 2024 Annual Meeting of the Urological Surgeons Branch of the Chinese Medical Association (CUDA) was held in Xi’an from August 8 to 11, 2024. The conference, organized by the Chinese Medical Association and the CUDA Urological Surgeons Branch, was hosted by the Air Force Medical University Xijing Hospital and co-organized by the Shaanxi Provincial…
-

Dr. Hailiang Zhang: Analyzing the Characteristics of Chinese UTUC Patients and Exploring Targeted Treatment Strategies to Meet the Needs of More UTUC
Upper tract urothelial carcinoma (UTUC), which includes renal pelvis cancer and ureteral cancer, is classified alongside bladder cancer as a type of urothelial carcinoma. However, the overall incidence of UTUC is relatively low, and there are still some contentious issues in its diagnosis and treatment strategies. At the recent 2024 Annual Meeting of the Urological…